Cytomegalovirus in solid organ transplantation.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 1, doi. 10.1034/j.1399-3062.2001.00001.x
- By:
- Publication type:
- Article
Works matching IS 13982273 AND DT 2001 AND VI 3 AND IP s1
Results: 11
1
2
Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 6, doi. 10.1034/j.1399-3062.2001.00002.x
- By:
- Publication type:
- Article
3
Economic impact of cytomegalovirus in solid organ transplantation.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 14, doi. 10.1034/j.1399-3062.2001.00003.x
- By:
- Publication type:
- Article
4
Cytomegalovirus drug resistance and clinical implications.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 20, doi. 10.1034/j.1399-3062.2001.00004.x
- By:
- Publication type:
- Article
5
Human CMV-IGIV (CytoGam®) neutralizes human cytomegalovirus (HCMV) infectivity and prevents intracellular signal transduction after HCMV exposure.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 25, doi. 10.1034/j.1399-3062.2001.00005.x
- By:
- Publication type:
- Article
6
Antibody inhibition of cytomegalovirus: the role of natural killer and macrophage effector cells.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 31, doi. 10.1034/j.1399-3062.2001.00006.x
- By:
- Publication type:
- Article
7
Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 35, doi. 10.1034/j.1399-3062.2001.00007.x
- By:
- Publication type:
- Article
8
Hypogammaglobulinemia after heart transplantation: impact of pre-emptive use of immunoglobulin replacement (CytoGam®) on infection and rejection outcomes.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 40, doi. 10.1034/j.1399-3062.2001.00008.x
- By:
- Publication type:
- Article
9
Role of cytomegalovirus in cardiac allograft vasculopathy.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 44, doi. 10.1034/j.1399-3062.2001.00009.x
- By:
- Publication type:
- Article
10
Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in lung transplantation.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 49, doi. 10.1034/j.1399-3062.2001.00010.x
- By:
- Publication type:
- Article
11
Multicenter US study of hospital resource utilization associated with cytomegalovirus-related readmission of renal and heart transplant patients.
- Published in:
- Transplant Infectious Disease, 2001, v. 3, n. s1, p. 57, doi. 10.1034/j.1399-3062.2001.00011.x
- By:
- Publication type:
- Article